The connection between obesity and cancer risk continues to be a significant area of study, with recent findings indicating that weight loss may lower cancer risk. A 2023 study compared GLP-1 weight loss drugs with bariatric surgery, showing similar incidences of obesity-related cancer in both groups. Experts note that while bariatric surgery leads to more significant weight loss, GLP-1 drugs also effectively reduce cancer risk through various mechanisms. Additionally, there is a call for more research on weight management for individuals diagnosed with cancer, considering the growing association between obesity and cancer types.
The incidence of obesity-related cancer was similar among those treated with GLP-1RA and with bariatric surgery, suggesting both treatments are effective in cancer risk reduction.
The protective effects of GLP-1RAs against obesity-related cancers likely arise from multiple mechanisms, including reducing inflammation, according to Dr. Dicker.
Weight management in people recently diagnosed with cancer is critical in terms of outcomes, pointing to a need for further exploration in this area.
Higher amounts of body fat are associated with an increased risk of several cancers, highlighting the ongoing relevance of obesity in cancer research.
Collection
[
|
...
]